DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Brilacidin is an investigational drug.
There have been 3 clinical trials for Brilacidin. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2015.
The most common disease conditions in clinical trials are Mouth Diseases, Head and Neck Neoplasms, and Skin Diseases, Infectious. The leading clinical trial sponsors are Cellceutix Corporation, Innovation Pharmaceuticals, Inc., and [disabled in preview].
Recent Clinical Trials for Brilacidin
|A Study to Investigate the Use of Delayed Release Tablets for Colonic Delivery of Brilacidin in Healthy Volunteers||Innovation Pharmaceuticals, Inc.||Phase 1|
|Phase 2 Study to Evaluate the Safety & Efficacy of Brilacidin Oral Rinse in Patients With Head and Neck Cancer||Cellceutix Corporation||Phase 2|
|Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections||Cellceutix Corporation||Phase 2|